Skip to main content
TipRanks
Go Ultimate75% OFF

Sienna Biopharmaceuticals (SNNAQ) Income Statement

71 Followers

Sienna Biopharmaceuticals Income Statement

Last quarter (Q3 2019), Sienna Biopharmaceuticals's total revenue was $0.00. In Q3, Sienna Biopharmaceuticals's net income was $-3.97M. See Sienna Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 18Dec 17
$ 0.00$ 0.00
$ -157.00K$ -120.00K
$ 76.50M$ 48.57M
Depreciation and Amortization$ 157.00K$ 120.00K
$ -76.34M$ -48.45M
$ -76.50M$ -48.57M
$ 3.03M$ -2.26M
$ -73.47M$ -50.84M
$ -73.31M$ -50.55M
Per Share Metrics
Basic EPS$ -3.59$ -5.19
Diluted EPS$ -3.59$ -5.19
Weighted Average Shares Outstanding20.45M9.73M
Weighted Average Shares Outstanding (Diluted)20.45M9.73M

Currency in USD

Sienna Biopharmaceuticals Earnings and Revenue History

-90M-60M-30M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20172018RevenueEarningsProfit Margin